Zen hospital opens dedicated cancer facility
According to the Indian Council of Medical Research (ICMR), there will be an estimated 12 % rise in cancer cases in India in the next five years
According to the Indian Council of Medical Research (ICMR), there will be an estimated 12 % rise in cancer cases in India in the next five years
The investment will accelerate the overall Sarclisa development program
He has over 25 years of rich experience in marketing and business in various sectors
The single in vitro diagnostic test helps inform therapy decisions according to clinical guidelines to enable precision medicine earlier in the disease journey
RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology-related deals dominate the landscape
Guardant360 CDx is a comprehensive genomic profiling test that utilizes blood samples from patients with advanced solid cancers
Lynparza is approved in the US, EU, Japan and several other countries for the treatment of patients with gBRCAm, HER2-negative, metastatic breast cancer previously treated with chemotherapy based on results from the OlympiAD Phase III trial
The study met its primary endpoint and showed equivalent efficacy and a comparable safety profile
Experts will speak about primary tumours of the nervous system and also the tumours of other body parts which get metastasized to the nervous system
The studies demonstrate a standardized strategy to extend mechanistic modeling and systems pharmacology into drug safety and mode of action assessments that has relevance for drug development and a variety of other contexts
Subscribe To Our Newsletter & Stay Updated